Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma

Biochemical and Biophysical Research Communications

Volumn 375, Issue 1, 2008, Pages 1-5

  Guo, Ying ^a   Pajovic, Sanja ^a   Gallie, Brenda L ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

MDM2; MDM4; p14ARF; Retinoblastoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN MDM2; PROTEIN MDMX; MDM2 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; ADOLESCENT; ADULT; BIOSYNTHESIS; GENETICS; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RETINA; RETINA TUMOR;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MDM2; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 50949109786     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.055     Document Type: Article

References (36)

1. Berger J.H., and Bardeesy N. Modeling INK4/ARF tumor suppression in the mouse. Curr. Mol. Med. 7 (2007) 63-75
2. Sherr C.J. Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6 (2006) 663-673
3. Kim W.Y., and Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 127 (2006) 265-275
4. Gil J., and Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 7 (2006) 667-677
5. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., and Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91 (1997) 649-659
6. Honda R., and Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18 (1999) 22-27
7. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., and Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1 (1999) 20-26
8. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., and Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12 (1998) 2424-2433
9. de Stanchina E., McCurrach M.E., Zindy F., Shieh S.Y., Ferbeyre G., Samuelson A.V., Prives C., Roussel M.F., Sherr C.J., and Lowe S.W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12 (1998) 2434-2442
10. Palmero I., Pantoja C., and Serrano M. P19ARF links the tumour suppressor p53 to Ras. Nature 395 (1998) 125-126
11. Lowe S.W., and Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13 (2003) 77-83
12. Laurie N.A., Donovan S.L., Shih C.S., Zhang J., Mills N., Fuller C., Teunisse A., Lam S., Ramos Y., Mohan A., Johnson D., Wilson M., Rodriguez-Galindo C., Quarto M., Francoz S., Mendrysa S.M., Guy R.K., Marine J.C., Jochemsen A.G., and Dyer M.A. Inactivation of the p53 pathway in retinoblastoma. Nature 444 (2006) 61-66
13. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.W., Cordon-Cardo C., and DePinho R.A. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92 (1998) 713-723
14. Zhang Y., Xiong Y., and Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92 (1998) 725-734
15. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M.F., and Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95 (1998) 8292-8297
16. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H., and Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17 (1998) 5001-5014
17. Nork T.M., Poulsen G.L., Millecchia L.L., Jantz R.G., and Nickells R.W. P53 regulates apoptosis in human retinoblastoma. Arch. Ophthalmol. 115 (1997) 213-219
18. Kato M.V., Shimizu T., Ishizaki K., Kaneko A., Yandell D.W., Toguchida J., and Sasaki M.S. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma. Cancer Lett. 106 (1996) 75-82
19. Shvarts A., Steegenga W.T., Riteco N., van Laar T., Dekker P., Bazuine M., van Ham R.C., van der Houven van Oordt W., Hateboer G., van der Eb A.J., and Jochemsen A.G. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15 (1996) 5349-5357
20. Reid T.W., Albert D.M., Rabson A.S., Russell P., Craft J., Chu E.W., Tralka T.S., and Wilcox J.L. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53 (1974) 1347-1360
21. McFall R.C., Sery T.W., and Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 37 (1977) 1003-1010
22. Gallie B.L., Campbell C., Devlin H., Duckett A., and Squire J.A. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 59 (1999) 1731s-1735s
23. Corson T.W., and Gallie B.L. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46 (2007) 617-634
24. Komori H., Enomoto M., Nakamura M., Iwanaga R., and Ohtani K. Distinct E2F-mediated transcriptional program regulates p14ARF gene expression. EMBO J. 24 (2005) 3724-3736
25. Robertson K.D., and Jones P.A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol. 18 (1998) 6457-6473
26. Tannapfel A., Busse C., Weinans L., Benicke M., Katalinic A., Geissler F., Hauss J., and Wittekind C. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20 (2001) 7104-7109
27. Esteller M., Cordon-Cardo C., Corn P.G., Meltzer S.J., Pohar K.S., Watkins D.N., Capella G., Peinado M.A., Matias-Guiu X., Prat J., Baylin S.B., and Herman J.G. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res. 61 (2001) 2816-2821
28. Watanabe T., Nakamura M., Yonekawa Y., Kleihues P., and Ohgaki H. Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas. Acta Neuropathol. (Berl.) 101 (2001) 185-189
29. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
30. Honda R., Tanaka H., and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420 (1997) 25-27
31. Hopkins-Donaldson S., Belyanskaya L.L., Simoes-Wust A.P., Sigrist B., Kurtz S., Zangemeister-Wittke U., and Stahel R. P53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma. Neoplasia 8 (2006) 551-559
32. Shvarts A., Bazuine M., Dekker P., Ramos Y.F., Steegenga W.T., Merckx G., van Ham R.C., van der Houven van Oordt W., van der Eb A.J., and Jochemsen A.G. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics 43 (1997) 34-42
33. Marine J.C., Dyer M.A., and Jochemsen A.G. MDMX: from bench to bedside. J. Cell Sci. 120 (2007) 371-378
34. Toledo F., and Wahl G.M. MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int. J. Biochem. Cell Biol. (2007)
35. Dimaras H., Khetan V., Halliday W., Orlic M., Prigoda N.L., Piovesan B., Marrano P., Corson T.W., Eagle Jr. R.C., Squire J.A., and Gallie B.L. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum. Mol. Genet. 17 (2008) 1363-1372
36. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol. Clin. North Am. 18 (2005) 41-53